Scienture Holdings, Inc. (SCNX)

Scienture Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Scienture Holdings, Inc. (SCNX) is a Medical - Healthcare Information Services company based in US with a market capitalization of $6.4M. Revenue grew 215.9% year-over-year and free cash flow was negative at -$13.4B. This page tracks SCNX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 14 employees · IPO Feb 6, 2014

Valuation

Valuation & price

$0.40as of May 17, 2026· -84.5% vs 52w high

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$2.60$1.44$0.28Jul 25Dec 25Jul 26
$0.2452-week range$2.60
Loading valuation history…

Fundamentals

Key fundamentals

$6.4M

Market cap

215.9%

Revenue growth (YoY)

76.8%

Gross margin

-$13.4B

Free cash flow (USD)

-$6.6B

Net debt

Net cash position

4446.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$2.5M$431.6K

Free cash flow by year

20162025

-$1.3M-$13.4B

Gross margin by year

20212025

48.0%76.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 15, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventMay 29, 2026Filing

    CFO Resignation and Appointment

  • 8-K eventMay 22, 2026Filing

    Earnings Release

  • Quarterly reportMay 15, 2026Filing

    10-Q Filed

  • 8-K eventMay 5, 2026Filing

    Investor Presentation Posted

  • 8-K eventMay 1, 2026Filing

    Note Purchase Agreement

  • Annual reportApr 30, 2026Filing

    10-K Filed

Questions

Frequently asked questions

What is Scienture Holdings, Inc.'s market cap?

Scienture Holdings, Inc. (SCNX) has a market capitalization of $6.4M.

What is SCNX's P/E ratio?

A meaningful P/E ratio is not available for SCNX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SCNX's price-to-book (P/B) ratio?

SCNX trades at 0.00 times book value per share.

Are insiders buying SCNX stock?

SEC Form 4 filings show no open-market insider buys at Scienture Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Information Services

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.